Analyst at Zacks Research Pvt. Ltd.
Contributor's Links: Zacks Investment Research

Arpita has been an equity analyst at Zacks Investment Research since March, 2004.

ALL CONTRIBUTIONS

Two Key FDA Decisions To Watch Out For In January 2017
Several drug companies could see regulatory milestones passed in January 2017. Here's a look at a couple of important regulatory events scheduled for this month.
Read
Cempra Plunges To 52-Week Low, Shire Drug Label Expanded
It was a relatively slow week for pharma stocks though a couple of companies suffered regulatory setbacks with the FDA issuing complete response letters (CRLs) for their regulatory applications.
Read
J&J Back In Talks With Actelion, Teva Settles Corruption Probe
Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal.
Read
4 Biotech Stocks That More Than Doubled In 2016
2016 has not been a great year for biotech stocks, which were under intense pressure with issues like increasing political and media focus on high price tags for drugs, and the changing competitive scenario weighing on the sector.
Read
Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug
Conatus is ending the year on a high note with the company signing a lucrative deal with Swiss pharma giant, Novartis. Investors applauded the deal sending the company’s shares soaring 141.3%.
Read
Actelion Remains In M&A Spotlight, ASH Data In Focus
Switzerland-based Actelion continued to be a part of acquisition chatter with Sanofi now rumored to be interested in the company.
Read

STOCKS I FOLLOW

ABBV AbbVie Inc.
AMGN Amgen Inc.
CVS CVS Health Corporation
ESRX Express Scripts Inc.
GOOGL Google (A shares)
INTC Intel Corporation
LLY Eli Lilly and Company
QCOM QUALCOMM Incorporated
SNY Sanofi
TEVA Teva Pharmaceutical Industries Limited
UNH UnitedHealth Group Inc.
Load More

TWEETS

LATEST ACTIVITY

Arpita Dutt Just joined TalkMarkets.
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Equity Analyst
Zacks Research Pvt. Ltd.
March 2004 - Present (13 years 1 month)

Education

Institute of Chartered Accountants of India
Chartered Accountant
1998 / 2004
Loreto House, Calcutta
ICSE
1986 / 1992

Publications